Optimal use of mass spec scan modes to characterize an unknown metabolite (original) (raw)

Metabolism of glycyrrhetic acid by rat liver microsomes—II

Yasuhiro Tezuka

Biochemical Pharmacology, 1990

View PDFchevron_right

Metabolism of MK-0524, a Prostaglandin D2Receptor 1 Antagonist, in Microsomes and Hepatocytes from Preclinical Species and Humans

marius braun

Drug Metabolism and Disposition, 2006

View PDFchevron_right

Contributions of human cytochrome P450 enzymes to glyburide metabolism

Mary Hebert

Biopharmaceutics & Drug Disposition, 2010

View PDFchevron_right

Characterization of metabolites of a NK1 receptor antagonist, CJ-11,972, in human liver microsomes and recombinant human CYP isoforms by liquid chromatography/tandem mass spectrometry

Chandra Agarwal

Rapid Communications in Mass Spectrometry, 2007

View PDFchevron_right

Development and implementation of a stereoselective normal-phase liquid chromatography–tandem mass spectrometry method for the determination of intrinsic metabolic clearance in human liver microsomes☆

Anne Rose

Journal of Chromatography B, 2008

View PDFchevron_right

Metabolomics in toxicology and preclinical research

Hennicke Kamp

ALTEX, 2013

View PDFchevron_right

Metabolism of ciamexon by human liver microsomes: an investigation into the formation of stable, chemically reactive and cytotoxic metabolites

Malcolm Tingle

British Journal of Clinical Pharmacology, 1990

View PDFchevron_right

In vitro and in vivo studies on the metabolism of 1,3-diaminobenzene: Comparison of metabolites formed by the perfused rat liver, primary rat hepatocyte cultures, hepatic rat microsomes and the whole rat

Hong Anh Nguyen Lam

Toxicology in Vitro, 1989

View PDFchevron_right

Metabolomics – an analytical strategy for identification of toxic mechanism of action

Kasper Skov

2015

View PDFchevron_right

Gundert Remy 2014 Drug Metabolism Reviews

Philip Fischer

View PDFchevron_right

Targeted metabolomics in cultured cells and tissues by mass spectrometry: Method development and validation

Anas Abdel Rahman

View PDFchevron_right

Roles of FMO and CYP450 in the Metabolism in Human Liver Microsomes of S-Methyl-N,N-Diethyldithiocarbamate, a Disulfiram Metabolite

Stephen Naylor

Alcoholism: Clinical & Experimental Research, 1999

View PDFchevron_right

Comparison of metabolic stability and metabolite identification of 55 ECVAM/ICCVAM validation compounds between human and rat liver homogenates and microsomes - a preliminary analysis

Jouko Uusitalo

ALTEX, 2009

View PDFchevron_right

An optimized procedure for metabonomic analysis of rat liver tissue using gas chromatography/time-of-flight mass spectrometry

Wei Jia

Journal of Pharmaceutical and Biomedical Analysis, 2010

View PDFchevron_right

Metabolism of methylstenbolone studied with human liver microsomes and the uPA+/+-SCID chimeric mouse model

Vinod Nair

Biomedical Chromatography, 2014

View PDFchevron_right

Kinetics of glyburide metabolism by hepatic and placental microsomes of human and baboon

mahmoud ahmed

Biochemical Pharmacology, 2007

View PDFchevron_right

Metabolomics in Toxicology: Preclinical and Clinical Applications

Donald Robertson

Toxicological Sciences, 2011

View PDFchevron_right

Handbook of Drug Metabolism

Patricia Kasar

View PDFchevron_right

Studies of metabolite–protein interactions: A review

JOHN MARK BADILLA

Journal of Chromatography B, 2014

View PDFchevron_right

Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide

Donald Mattison

Biochemical Pharmacology, 2009

View PDFchevron_right

The metabolism of 1-hydroxy- and 2-hydroxy-3-methylcholanthrene by liver microsomes: Effect of enzyme inducing agents

Edith Gardiner

Cancer Letters, 1984

View PDFchevron_right

Using mass spectrometry for drug metabolism studies

Ragu Ramanathan, W. Korfmacher

Journal of the American Society for Mass Spectrometry, 2006

View PDFchevron_right

An untargeted metabolomic strategy based on liquid chromatography-mass spectrometry to study high glucose-induced changes in HK-2 cells

marina alegre

Journal of Chromatography A, 2019

View PDFchevron_right

Metabolism: A Bottleneck in In Vitro Toxicological Test Development The Report and Recommendations of ECVAM Workshop 541

Andreas Richert

View PDFchevron_right

DRUG METABOLISM- CLINICAL PHARMACOLOGY

magendira mani vinayagam

View PDFchevron_right

Pitfalls to be considered on the metabolomic analysis of biological samples by HR-MAS

Vicent Esteve

Frontiers in Chemistry, 2014

View PDFchevron_right

Metabolite Profiling of a NIST Standard Reference Material for Human Plasma (SRM 1950): GC-MS, LC-MS, NMR, and Clinical Laboratory Analyses, Libraries, and Web-Based Resources

dmitrii tchekhovskoi

Analytical Chemistry, 2013

View PDFchevron_right

Metabolism and Disposition of n-Butyl Glycidyl Ether in F344 Rats and B6C3F1 Mice

EMILY I . NWAKPUDA

Drug Metabolism and Disposition, 2007

View PDFchevron_right

Thein vitro metabolism of desglymidodrine, an active metabolite of prodrug midodrine by human liver microsomes

Masayuki Akimoto

European Journal of Drug Metabolism and Pharmacokinetics, 2004

View PDFchevron_right